Ambitious new 10-year life sciences vision for UK

The government has published a new UK Life Sciences Vision setting out a 10-year strategy. Using the sector’s remarkable successes during COVID-19 as a blueprint, it aims to speed up the delivery of innovations to patients.

Co-developed with industry experts and business leaders, the vision outlines seven key missions on which the government, industry, the NHS, universities and charities will collaborate to solve some of our generation’s biggest healthcare issues.

The missions are:

  • Accelerating research on new dementia treatments
  • Enabling earlier diagnosis and treatment of disease, including cancer vaccines and other immune therapies
  • Supporting British vaccine research, development and manufacturing
  • Treatment and prevention of cardiovascular disease
  • Reducing incidence of and deaths from respiratory disease in the UK and worldwide
  • Researching the biology of ageing
  • Improving understanding and treatment of mental illness, including redefining conditions

 

Britain’s life sciences sector has been at the heart of the battle against COVID-19, from the UK Vaccines Taskforce and the Oxford-AstraZeneca vaccine to the RECOVERY trial, a world-leading project to identify safe and effective medications.

The Vision aims to emulate these successes, cutting red tape and leveraging private expertise to solve challenges at speed and at risk. It will take full advantage of new regulatory freedoms offered by Brexit, and is the first sectoral publication that builds on the government’s Plan for Growth, which aims to “level up” the UK into a world-leading centre for innovation and jobs of the future.

The Vision aims to cultivate a UK business environment where life sciences companies can access the funding they need to grow and innovate, are regulated in an efficient and agile way, and are incentivised to make and sell their products in the UK.

The government is putting its money where its mouth is with the simultaneous launch of a new £200 million Life Sciences Investment Programme, which has increased funding available for promising UK life sciences companies to £1 billion.

The life sciences sector employs over 250,000 people and generates an £80 billion turnover  every year. One of the Vision’s key themes is supporting growth in the sector, attracting more investment and creating highly skilled jobs throughout the UK.

Recent Posts

AI in recruitment: are the rewards worth the risks? September 16, 2021

AI is now being used to automate recruitment more than ever before. AI tools can scan CVs, analyse video interviews, and compare them with successful past applications to spot personality traits that fit the role, allegedly eliminating human bias.

5 tech career myths busted September 9, 2021

Are any of these hoary myths scaring you away from a successful tech career? The tech industry is expanding 2.6 times faster than the UK economy as a whole, according to figures from Tech Nation. This has led to a tech jobs boom, with tech employment in the UK growing by 40% between 2017 and 2019, and tech jobs around 20 times more in demand than creative roles.

How to break into the gaming industry September 2, 2021

Working in the gaming industry is a dream for many gamers, but it can be hard to know how to turn it into reality. What options are open to you, and how can you train and prepare for them?